Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor

Fig. 3

Forest plot of the hazard ratios of clinical outcomes for SGLT2i versus DPP4i among patients with type-2 diabetes mellitus (T2DM) comorbid with peripheral artery disease (PAD) after propensity score matching (PSM). SGLT2i were associated with a comparable risk of thromboembolic events and with lower risks of CHF, lower limb revascularization or amputation, and all-cause or cardiovascular mortality compared with DPP4i among patients with T2DM and concomitant PAD after PSM. Abbreviation: CI confidence interval, HR hazard ratio. Other abbreviations are the same as those in Figs. 1, 2

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840